Mark G. Foletta, Director at DEXCOM INC (DXCM), sold 1,729 shares at $341.79 ($591K) on 2020-11-16, disclosed to the SEC on 2020-11-18.
Open-market sale of $591k DXCM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $336.98 | 15 | $5K | 0.9% |
| 2 | $337.78 | 139 | $47K | 7.9% |
| 3 | $340.23 | 117 | $40K | 6.7% |
| 4 | $341.79 | 428 | $146K | 24.8% |
| 5 | $341.79 | 428 | $146K | 24.8% |
| 6 | $342.93 | 301 |
| $103K |
| 17.5% |
| 7 | $342.93 | 301 | $103K | 17.5% |
| Total | $341.72 avg | 1,729 | $591K | 100% |
| Filing → |
| DXCM | SELL | 2026-06-17 | $297K | — | Filing → |
| DXCM | SELL | 2025-08-18 | $430K | — | Filing → |
| DXCM | SELL | 2025-07-17 | $468K | — | Filing → |